Clin Rheumatol 2020 Aug 15
Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapy.
Related Questions
How does the management differ if the cancer is resectable or requires systemic treatment?
New answer by at Cedars-Sinai Medical Center (June 5, 2025)
The story here is an important one. I was able to discuss this with @Jonathan Kay, who supplied important insights. Most of the good (and bad) data supporting what to do when ...